HARTMANN at a glance
HARTMANN is a leading international manufacturer of medical and hygiene products.
In a world where health is becoming an increasingly important matter and is managed more professionally, we offer our customers simple and effective solutions for the benefit of the patients. This is expressed in our brand promise of “Going further for health”. Professional solutions for wound treatment, incontinence hygiene and infection prevention form the core of our portfolio.
In 2016, we employed 10,372 staff worldwide and generated sales of EUR 1,986 million.
The HARTMANN solutions
Our focus is on products and services for professional users in hospitals, medical practices, nursing homes and homecare services. In addition, we also offer OTC products for end consumers sold through pharmacies and medical supply stores.
Our Wound Management solutions comprises traditional and modern wound dressings; bandages for compression therapy, and immobilisation; specifically designed treatment sets for a broad range of medical applications; and the Vivano negative-pressure wound therapy system. These product lines are rounded out by First Aid kits and diagnostic products such as clinical thermometers and blood pressure monitors.
Share of total sales by business segment
in EUR million and percent
In the Incontinence Management segment, the focus is on absorbent products worn close to the body, such as briefs, pads and pants, as well as products for use as additional bed protection, such as underpads. This segment also includes disposable products for patient care, such as wash gloves and bibs, and medical skincare products for stressed skin. We go even further by offering integrated solutions for old people’s and nursing homes with services ranging from logistics to controlling.
Through Infection Management we offer a range of disposable operating theater drapes, clothing, surgical absorbents and disposable surgical instruments. We go further through the HARTMANN delivery service (HLS) and individually designed custom procedure trays – all designed to create efficiency in hospitals. Disinfectants and cleaning agents as well as examination gloves round out our range of products and services for comprehensive infection prophylaxis.
Other Group Activities comprises our activities in cosmetic cotton-wool products, first aid, Kneipp product lines and retail business.
Share of total sales by region
in EUR million and percent
Shares of regions in total sales of the HARTMANN GROUP (in million euros and as a percentage; discrepancies due to rounding not adjusted).
We are present in over 30 countries with our own sales and manufacturing organisations, but our solutions are available in around 100 countries through a network of distributors. You can find our offices in a number of countries throughout Europe, but we are also present in America, Africa, Asia, and Oceania.
In Germany, the HARTMANN GROUP includes, among others, the companies BODE Chemie/Hamburg, Karl Otto Braun/Wolfstein, Sanimed/Ibbenbüren and Kneipp/Würzburg.
With growth of 2.3% compared to the prior year, the HARTMANN GROUP achieved sales of EUR 1,986.5 million. EBIT improved by 4.9% to EUR 139.1 million. The Group's earnings after taxes amounted to EUR 90.1 million, which is 6.3% higher than in the prior year.
|in EUR thousand||2015||2016||Year-on-year
|Sales revenues||1,941,004|| 1,986,450
|Of which outside Germany in %||66.1||65.8||-0.5|
|Consolidated net income||84,778||90,100||6.3|
|Net return on sales in %||4.4||4.5||3.8|
|Cost of materials||869,469||868,065||-0.2
|Return on EBIT DA in %||10.3||10.6||3.0|
tangible and intangible assets
|Return on EBIT in %||6.6|| 7.0
|Balance Sheet total||1,278,619||1,329,339||4.0|
|Investments in tangible and
intangible assets 2
|Equity capital and reserves||759,098||816,208||7.5|
|Equity/asset ratio in %||59.4||61.4||3.4|
|Return on equity in %||11.2||11.0
|Net Financial Status||44,609||101,955
|Employees as at Dec. 31 1)||10,346||10,372||0.3|
1) Excl. staff on parental leave and PAUL HARTMANN AG Management Board members
2) Excluding investments from acquisitions like goodwill